secwatch.observer — SEC 8-K summary
======================================

Issuer:     TAO Synergies Inc. (TAOX)
CIK:        0001571934
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001104659-23-114810
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Synaptogenix invests up to ~$3.44M in Cannasoul Analytics for preferred shares and convertible notes
--------------------------------------------------------------------------------

- Initial investment: $562,770 for 12,737 Series A preferred shares (5% stake) at $44.1550/share.
- Initial convertible note of $1.44M; up to $2M in milestone notes subject to Cannasoul revenue/expense goals.
- Synaptogenix gets 3 of 7 board seats, veto power on 4th, preemptive rights, and veto over major transactions.
- Collaboration agreement to form joint research committee for cannabinoid compounds from Technion lab.
- If Cannasoul misses milestones, investor loses board rights and preferred shares may be converted to ordinary shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1571934/000110465923114810/0001104659-23-114810-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1571934/000110465923114810/tm2329972d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-114810

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer